MIM Pharma team is composed of experienced biopharma executives with a drive for transfer the legacy of deep-rooted-natural medicine to the modern pharmaceutical R&D and manufacturing techniques for introducing novel medical solutions for common annoying diseases such as Covid-19, migraine, and migraine-related diseases. The research and development team have achieved very promising results in treating these diseases. MIM Pharma management combines a wealth of talent and international experience in drug discovery and commercialization.
Peter Ressalehi
Chief Executive Officer
Dr. Reza Ramazani
Director of Operations and Senior Researcher
Mona Hedvig Myhre
Chief Business consultant
Saleh Ramazani
Director of Lab and Drug formulation
Fateme Azadinia
Director of Clinical Operations